全球百日咳疫苗市场规模（按疫苗类型、年龄层、分销管道、区域覆盖范围和预测）

百日咳疫苗市场规模及预测

百日咳疫苗市场规模在 2023 年价值 86.1277 亿美元，预计到 2032 年将达到 154.2981 亿美元，预测期内（2026-2032 年）的复合年增长率为 8.34%。

推动全球百日咳疫苗市场的因素

百日咳疫苗市场的市场驱动力可能受到多种因素的影响，其中包括：

百日咳发病率不断上升：百日咳疫情：百日咳疫情，也称为百日咳，继续在世界各地肆虐，越来越需要接种疫苗来阻止疾病的传播。

政府措施和疫苗接种计划许多政府和医疗保健组织积极推广百日咳疫苗接种作为常规免疫计划的一部分，包括针对婴儿、幼儿、青少年和成人的计划，有助于扩大该行业。

疫苗技术发展：由于疫苗研究技术的进步，百日咳疫苗接种正变得越来越新，也越来越安全。这些发展是研发资金的驱动力。

教育和宣传宣传活动：透过教育计画和宣传活动提高大众对百日咳疫苗接种价值的认识，对于增加需求至关重要。公众和医护人员意识的提高将有助于提高疫苗接种率。

医疗保健支出不断增加：百日咳疫苗市场因医疗保健支出不断增加而不断增长，尤其是预防保健支出，其中包括疫苗宣传活动资金和疫苗分发所需的基础设施。

儿童疫苗接种兴趣日益增长：随着人们对儿科医疗保健以及新生儿和儿童健康的日益关注，预计百日咳疫苗的需求将持续增长。百日咳疫苗通常被纳入小儿科疫苗接种计划，这推动了市场的成长。

全球化与旅行：便捷的全球旅行增加了百日咳等疾病传播的风险。百日咳特别流行的地区已经颁布了针对旅行者的疫苗接种法律，这促进了该行业的发展。

伙伴关係与协作：医疗保健提供者、政府机构、非营利组织和疫苗製造商之间的这些伙伴关係与协作正在透过促进疫苗的取得、分发和可负担性来帮助市场成长。

限制全球百日咳疫苗市场的因素

百日咳疫苗市场可能面临多种限制与挑战，包括：

知识和途径有限：在某些地区，特别是在低收入和偏远社区，人们对百日咳疫苗接种的了解有限，并且无法获得提供疫苗接种服务的医疗保健提供者的帮助，这可能会限制疫苗接种工作并阻碍市场扩张。

疫苗接种费用：百日咳疫苗接种费用可能是一个主要障碍，尤其是对于没有保险或在私人医疗机构就诊的人而言。这可能会导致部分人口因经济困难而无法接种疫苗，从而阻碍市场扩张。

疫苗分发和储存挑战：百日咳疫苗通常需要特殊的储存条件，例如冷藏，这在物流方面可能具有挑战性，尤其是在农村和人口稀少的地区。维护低温运输会增加整个过程的复杂性和成本。

疫苗厌恶和安全疑虑：与任何医疗程序一样，疫苗接种可能会引起某些人群和群体的安全疑虑。资讯不准确以及对医疗保健提供者缺乏信任可能会导致人们犹豫接种疫苗，从而阻碍市场成长并降低疫苗接种率。

监管障碍：不同国家和地区对疫苗分销和批准的规定各不相同。疫苗製造商可能难以遵守严格的临床试验和生产流程规定，这可能会阻碍疫苗的成长和进入新市场。

竞争环境：百日咳疫苗市场存在多家疫苗生产商，竞争激烈，可能导致定价压力和利润率下降。企业可能难以有效地实现产品差异化并抢占市场占有率。

公共卫生政策与资金筹措：百日咳疫苗接种需求可能会受到公共卫生政策变化、政府免疫计画资金筹措变化以及医疗保健预算波动的影响。长期资金筹措和政策变化的不确定性可能会导致市场波动。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

4. 百日咳疫苗市场（依疫苗类型）

• 全细胞百日咳疫苗
• 无细胞百日咳疫苗

第五章百日咳疫苗市场（依年龄层）

• 婴儿
• 孩子们
• 成人

6. 百日咳疫苗市场（依分销管道）

• 医院和诊所
• 零售药局
• 网路药局

第七章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第八章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第九章 竞争态势

• 主要企业
• 市场占有率分析

第十章 公司简介

• Kubota
• Deluxe Agro Industries
• AGCO
• Bharat Industries
• Iseki & Co
• ALMACO
• Alvan Blanch
• Wuhan Acme Agro Tech.
• GlaxoSmithKline
• Sanofi Pasteur
• Pfizer Inc.
• Serum Institute of India Pvt Ltd

第十一章 市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十二章 附录

• 简称列表
• 来源和参考文献

Pertussis Vaccine Market Size And Forecast

Pertussis Vaccine Market size was valued at USD 8612.77 Million in 2023 and is projected to reach USD 15429.81 Million by 2032, growing at a CAGR of 8.34% during the forecast period 2026-2032.

Global Pertussis Vaccine Market Drivers

The market drivers for the Pertussis Vaccine Market can be influenced by various factors. These may include:

Growing Incidence of Pertussis: The market is significantly influenced by the growing prevalence of pertussis, also known as whooping cough. The necessity for immunisation to stop the disease's spread is growing as it continues to harm people all over the world.

Government Initiatives and Immunisation Programmes: As part of regular vaccination schedules, a number of governments and healthcare organisations are actively promoting immunisation against pertussis. Programmes aimed for babies, kids, teens, and adults are included in this, which helps the industry expand.

Technological Developments in Vaccines: Newer and safer pertussis vaccinations have been made possible by technological advancements in vaccine research. Growth in the market is fueled by these developments, which draw funding for R&D.

Education and Public Awareness Campaigns: Raising public awareness of the value of the pertussis vaccination through educational programmes and campaigns is essential to increasing demand. Vaccine uptake is boosted by greater awareness among the general public and healthcare professionals.

Increase in Healthcare Spending: The market for pertussis vaccine is growing as a result of the general increase in healthcare spending, especially in preventative healthcare measures. This covers funding for immunisation campaigns and the infrastructure needed to distribute vaccines.

Growing Interest in Paediatric Vaccination: There will likely be a continued high demand for pertussis vaccines due to the increased attention being paid to paediatric healthcare and the health of newborns and children. Pertussis vaccine is frequently included in paediatric vaccination schedules, which is fueling market expansion.

Globalisation and Travel: The ease with which people can travel the world has raised the possibility of spreading diseases, such as pertussis. Traveller vaccination laws, particularly in areas where pertussis is more common, aid in the growth of the industry.

Partnerships and Collaborations: These partnerships and collaborations assist market growth by facilitating vaccine access, distribution, and affordability between healthcare providers, government agencies, non-profit organisations, and vaccine makers.

Global Pertussis Vaccine Market Restraints

Several factors can act as restraints or challenges for the Pertussis Vaccine Market. These may include:

Limited Knowledge and Access: There may be limited knowledge about the pertussis vaccination in some areas, particularly in low-income or isolated communities, or there may be limited access to medical facilities that provide vaccination services. This may impede market expansion by limiting the reach of immunisation initiatives.

Vaccination expense: The expense of the pertussis vaccination can be a major obstacle, especially for people without insurance or in private healthcare settings. Affordability concerns could prevent some demographic segments from receiving vaccinations, which would hinder market expansion.

Difficulties with Vaccine Distribution and Storage: Pertussis vaccinations frequently need particular storage environments, such refrigeration, which can be logistically difficult, particularly in rural or underdeveloped locations. Keeping the cold chain intact increases the process's complexity and expense.

Vaccine Hesitancy and Safety worries: Similar to any medical procedure, vaccinations may cause certain people or groups to have safety worries. Inaccurate information or a lack of faith in medical institutions can cause vaccine hesitation, which can impede market growth and reduce immunisation rates.

Regulatory Obstacles: varied nations and areas have varied regulatory regulations for the distribution and licencing of vaccines. For vaccine producers, adhering to strict regulations on clinical studies and manufacturing procedures can be difficult, which might hinder their ability to enter and grow new markets.

Competitive Environment: There may be pressure on prices and lower profit margins due to the existence of several vaccine makers and competition in the Pertussis Vaccine Market. Businesses may encounter difficulties efficiently differentiating their products and gaining market share.

Public Health Policies and financing: The demand for pertussis vaccinations may be impacted by modifications to public health policies, changes in government financing for immunisation programmes, and variations in healthcare budgets. Market volatility may result from unclear long-term funding or policy changes.

Global Pertussis Vaccine Market Segmentation Analysis

The Global Pertussis Vaccine Market is Segmented on the basis of Type of Vaccine, Age Group, Distribution Channel, and Geography.

Pertussis Vaccine Market, By Type of Vaccine

• Whole-cell Pertussis Vaccines: These vaccines contain whole, killed Bordetella pertussis bacteria. They were the first type of pertussis vaccines developed and used widely in the past. However, they are associated with more side effects compared to acellular vaccines.
• Acellular Pertussis Vaccines: These vaccines contain purified components of the Bordetella pertussis bacteria, such as pertussis toxin, filamentous hemagglutinin, pertactin, and fimbriae. They are newer and generally have fewer side effects, making them preferred for routine immunization.

Pertussis Vaccine Market, By Age Group

• Infants: Pertussis vaccination in infants is crucial as they are more susceptible to severe complications of pertussis, such as pneumonia and seizures.
• Children: Continued vaccination during childhood ensures sustained protection against pertussis.
• Adults: Vaccination in adults, especially pregnant women and healthcare workers, helps prevent the transmission of pertussis to vulnerable populations.

Pertussis Vaccine Market, By Distribution Channel

• Hospitals and Clinics: These are primary channels for vaccination, especially for infants and children during routine healthcare visits.
• Retail Pharmacies: Increasingly important for adult vaccinations and convenience for individuals seeking booster doses.
• Online Pharmacies: Emerging as a convenient option for vaccine distribution, especially during the COVID-19 pandemic when remote access to healthcare services has become more prevalent.

Pertussis Vaccine Market, By Geography

• North America: Market conditions and demand in the United States, Canada, and Mexico.
• Europe: Analysis of the Pertussis Vaccine Market in European countries.
• Asia-Pacific: Focusing on countries like China, India, Japan, South Korea, and others.
• Middle East and Africa: Examining market dynamics in the Middle East and African regions.
• Latin America: Covering market trends and developments in countries across Latin America.

Key Players

• The major players in the Pertussis Vaccine Market are:
• Kubota
• Deluxe Agro Industries
• AGCO
• Bharat Industries
• Iseki & Co
• ALMACO
• Alvan Blanch
• Wuhan Acme Agro Tech.
• GlaxoSmithKline
• Sanofi Pasteur
• Pfizer Inc.
• Serum Institute of India Pvt Ltd

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Pertussis Vaccine Market, By Type of Vaccine

• Whole-cell Pertussis Vaccines
• Acellular Pertussis Vaccines

5. Pertussis Vaccine Market, By Age Group

• Infants
• Children
• Adults

6. Pertussis Vaccine Market, By Distribution Channel

• Hospitals and Clinics
• Retail Pharmacies
• Online Pharmacies

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Kubota
• Deluxe Agro Industries
• AGCO
• Bharat Industries
• Iseki & Co
• ALMACO
• Alvan Blanch
• Wuhan Acme Agro Tech.
• GlaxoSmithKline
• Sanofi Pasteur
• Pfizer Inc.
• Serum Institute of India Pvt Ltd

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References